| Income Statement |
| Operating Expenses | 7.88M |
|
| Research and Development Expense | 3.15M |
| Selling, General and Administrative Expense | 2.65M |
| Operating Income | -7.88M |
| Income Tax Expense | 3.07M |
| Net Income | -8.77M |
| Net Income Common Stock | -8.77M |
| Net Income Common Stock (USD) | -6.36M |
| Consolidated Income | -8.46M |
| Net Income to Non-Controlling Interests | 313.00K |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.03 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -5.70M |
| Earning Before Interest & Taxes (USD) | -4.13M |
| Weighted Average Shares | 214.11M |
| Weighted Average Shares Diluted | 214.11M |
| Balance Sheet |
| Cash and Equivalents | 21.44M |
| Cash and Equivalents (USD) | 15.54M |
| Investments | 158.67M |
| Investments Current | 61.47M |
| Investments Non-Current | 97.20M |
| Current Assets | 84.22M |
| Property, Plant & Equipment Net | 61.28M |
| Total Assets | 242.69M |
| Debt Current | 104.00K |
| Total Debt | 250.00K |
| Current Liabilities | 2.12M |
| Debt Non-Current | 146.00K |
| Total Liabilities | 13.50M |
| Accumulated Retained Earnings (Deficit) | -22.53M |
| Accumulated Other Comprehensive Income | 8.38M |
| Shareholders Equity | 226.62M |
| Shareholders Equity (USD) | 164.22M |
| Assets Non-Current | 158.48M |
| Total Debt (USD) | 181.16K |
| Liabilities Non-Current | 11.38M |
| Trade and Non-Trade Payables | 1.93M |
| Tax Liabilities | 10.02M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 94.00K |
| Net Cash Flow from Financing | 1.59M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.66M |
| Capital Expenditure | -544.00K |
| Issuance (Purchase) of Equity Shares | 1.06M |
| Issuance (Repayment) of Debt Securities | -31.00K |
| Net Cash Flow from Investing | -57.00K |
| Net Cash Flow from Operations | -6.17M |
| Effect of Exchange Rate Changes on Cash | -29.00K |
| Share Based Compensation | 1.24M |